首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Disruption of Ixodes scapularis anticoagulation by using RNA interference
【24h】

Disruption of Ixodes scapularis anticoagulation by using RNA interference

机译:利用RNA干扰破坏肩小肌的抗凝作用

获取原文
获取原文并翻译 | 示例
       

摘要

Ixodes scapularis ticks transm it many pathogens, including Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti. Vaccines directed against arthropod proteins injected into the host during tick engorgement could prevent numerous infectious diseases. Salp14, a salivary anticoagulant, poses a key target for such intervention. Salp14 is the prototypic member of a family of potential I. scapularis anticoagulants, expressed and secreted in tick saliva during tick feeding. RNA interference was used to assess the role of Salp14 in tick feeding. Salp14 and its paralogs were silenced, as demonstrated by the reduction of mRNA and protein specific for these antigens. Tick salivary glands lacking Salp14 had reduced anticoagulant activity, as revealed by a 60-80% reduction of anti-factor Xa activity. Silencing the expression of salp14 and its paralogs also reduced the ability of I. scapularis to feed, as demonstrated by a 50-70% decline in the engorgement weights. Because ticks have several anticoagulants, it is likely that the expression of multiple anticoagulants in I. scapularis saliva would have to be ablated simultaneously to abolish tick feeding. These studies demonstrate that RNA interference can silence I. scapularis genes and disrupt their physiologic function in vivo, and they identify vaccine candidates that can alter vector engorgement.
机译:肩cap骨传播许多病原体,包括伯氏疏螺旋体,吞噬无形体和微小巴贝氏菌。针对tick虫充血期间注入宿主的节肢动物蛋白的疫苗可以预防多种传染病。 Salp14是唾液抗凝剂,是此类干预的主要目标。 Salp14是潜在的肩I类抗凝剂家族的原型成员,在tick喂养期间在tick唾液中表达和分泌。 RNA干扰用于评估Salp14在in喂养中的作用。 Salp14及其旁系同源物被沉默,如对这些抗原特异的mRNA和蛋白质的减少所证明。缺乏Salp14的虱子唾液腺的抗凝活性降低,抗Xa因子活性降低了60-80%。沉默salp14的表达及其旁系同源物也降低了肩I鱼的摄食能力,这是因为饱腹体重下降了50-70%。由于tick具有几种抗凝剂,因此必须同时消融肩骨唾液中多种抗凝剂的表达,才能消除tick喂养。这些研究表明,RNA干扰可以使肩I肠杆菌基因沉默并破坏它们的体内生理功能,并且他们确定了可以改变载体充血的候选疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号